Literature DB >> 18582801

Predictive utility of the 6-minute walk distance on survival in patients awaiting lung transplantation.

Michael Patrick Tuppin1, Jennifer D Paratz, Angela T Chang, Helen E Seale, James R Walsh, Fiona D Kermeeen, Keith D McNeil, Peter M Hopkins.   

Abstract

BACKGROUND: The 6-minute walk distance (6MWD) is a widely used clinical indicator of exercise capacity. Although used as part of the assessment process in determining a candidate's suitability for lung transplantation (LT), the literature describing the impact of the 6MWD in predicting survival on LT waiting lists is limited. This study aimed to determine the hazard function associated with the 6MWD, and its utility relative to other prognostic variables.
METHODS: A retrospective chart review was conducted on 163 patients who were listed for single or double LT, and either survived to transplant or died while on the waiting list. A Cox regression for survival analysis, stratified by diagnostic group, was conducted utilizing the 6MWD, demographic variables and measures of cardiopulmonary function.
RESULTS: The 6MWD proved to be the only significant covariate in the Cox regression for survival analysis (p < 0.001), with all other variables eliminated as non-significant. Furthermore, there was a protective effect for each unit increase in the 6MWD [Exp (B) = 0.994, 95% confidence interval 0.990 to 0.997].
CONCLUSIONS: This research demonstrates that the 6MWD is useful for stratifying patients on the LT waiting list by identifying those patients with a significantly higher risk of mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18582801     DOI: 10.1016/j.healun.2008.03.017

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  8 in total

Review 1.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

Review 2.  Indications for lung transplant referral and listing.

Authors:  Omar Shweish; Goutham Dronavalli
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 3.  Lung transplantation: indications and contraindications.

Authors:  David Weill
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

4.  8-Foot-Up-and-Go Test is Associated with Hospitalizations and Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Pilot Study.

Authors:  Baruch Vainshelboim; Mordechai Reuven Kramer; Jonathan Myers; Avraham Unterman; Shimon Izhakian; Jose Oliveira
Journal:  Lung       Date:  2019-01-02       Impact factor: 2.584

5.  Physical function in older candidates for renal transplantation: an impaired population.

Authors:  Erica L Hartmann; Dalane Kitzman; Michael Rocco; Xiaoyan Leng; Heidi Klepin; Michelle Gordon; Jack Rejeski; Michael Berry; Stephen Kritchevsky
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-04       Impact factor: 8.237

6.  A 1-Month Physical Therapy-Based Outpatient Program for Adults Awaiting Lung Transplantation: A Retrospective Analysis of Exercise Capacity, Symptoms, and Quality of Life.

Authors:  Rebecca Byrd; Patrick Smith; Omar Mohamedaly; Laurie D Snyder; Amy M Pastva
Journal:  Cardiopulm Phys Ther J       Date:  2019-04

Review 7.  Relationship of Exercise Capacity, Physical Function, and Frailty Measures With Clinical Outcomes and Healthcare Utilization in Lung Transplantation: A Scoping Review.

Authors:  Nicholas Bourgeois; Shirin M Shallwani; Fahad S Al-Huda; Sunita Mathur; Charles Poirier; Tania Janaudis-Ferreira
Journal:  Transplant Direct       Date:  2022-10-07

8.  A functional assessment of patients two years after lung transplantation in Poland.

Authors:  Dariusz T Jastrzębski; Anna Gumola; Jacek Wojarski; Sławomir Żegleń; Marek Ochman; Damian Czyżewski; Dariusz Ziora; Marian Zembala; Jerzy Kozielski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.